Market Tracker

10/22 6:06pm ET

Incyte Corp (NASDAQ:INCY)

During the Trading Day
52.47 +0.03 / +0.06%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
52.47 0.00 / 0.00%
 
Volume: 10.1K

Today’s Trading

Previous close52.44
Today’s open52.56
Day’s range51.50 - 53.39
Volume575,323
Average volume (3 months)949,768
Market cap$8.8B
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+35.46%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-1.43-1.23%
SLXPSalix Pharmaceutical...-2.94-2.09%
HSPHospira Inc-0.80-1.57%
RDYDr.Reddy's Laborator...+0.49+0.99%
Data as of 4:03pm ET, 10/22/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts